2024 Partners
Proud to Partner with:
Biose Industrie
Lead Partner
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951 by pharmacists and microbiologists, Biose Industrie has been manufacturing drug substance and drug products based on microorganisms for 60 years. Company, with 10 000m² of GMP facilty, offers product development at laboratory and pilot scale specialised in microbiology for aerobie and anaerobie strains and is Drug GMP certified for the manufacturing of API, clinical batches and commercial products.
ReciBioPharm
Expertise Partner
Introducing ReciBioPharm, Recipharm’s biologics business combining the capabilities of recently acquired CDMOs Arranta Bio, GenIbet and Vibalogics. Our expanded biologics drug development and manufacturing services encompass technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, recombinant proteins, nucleic acid-based mRNA and plasmid DNA production. Established in 1995, Recipharm’s manufacturing, fill-finish, and delivery device services canvass a wide variety of drug dosage forms and modalities. Recipharm is an industry leading CDMO with over 30 facilities and 9,000 employees globally – servicing companies that are developing small-molecules, biologics, and drug device combinations.
Sacco System
Expertise Partner
Sacco System is the international biotech hub for food, nutraceutical, and pharmaceutical innovation. Cultures, probiotics, rennet, and many other ingredients to promote the culture of
food and life. Innovative and customized solutions capable of responding to modern challenges of the Food & Health sector worldwide.
After more than 70 years, CSL continue to focus on probiotic manufacturing, research and development for nutraceutical and pharmaceutical fields. Our know-how is not limited to LAB, but with our two facilities drug- GMP certified we can support companies in the development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria (obbligate aerobes and anaerobes strains) and biotherapeutics (BPs).
VCLS
Program Partner
Global regulatory science and clinical research consultancy, which guides biotechnology, pharmaceutical and MedTech manufacturers throughout product development and market access. From early stage to patients, VCLS assists innovators by designing product development strategies that optimize clinical development to drive commercial success. Integrated solutions with regulatory and market access development strategy, chemistry formulation, manufacturing scale-up & control services, nonclinical & clinical regulatory development planning, clinical research, safety monitoring and data management in USA, UK, France, Switzerland, Denmark, Madagascar, India and China
ProDigest
Innovation Partner
ProDigest is a product leader in the development of unique laboratory models of the human and animal gastrointestinal tract (SHIME®). These models allow you to obtain unique insight in gut processes associated to the intestinal fate of actives and to study the complete gut microbiome under controlled conditions. ProDigest is globally active as a service provider for food and pharmaceutical companies and installs its technology in selected R&D facilities around the world. Furthermore, ProDigest has set up a number of product development projects in relation to the gut microbiota management and novel biotherapeutics.
Bacthera
Exhibition Partner
Bacthera, a CDMO located in Switzerland and Denmark, was founded to enable the Live Biotherapeutic Industry realize the therapeutic value of LBP's. We do so by supporting our customers with microbiology know-how, process expertise and industry changing innovation from pre-clinical to commercialization, from start-up to multinational pharma company, with best-in-class process technologies, strictly anaerobic strain handling and experienced staff. In sum, Bacthera actively work to de-risk the growing LBP industry with frictionless CMC development services and manufacturing solutions.
Boston Analytical
Event Partner
Boston Analytical is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 accredited world class pharmaceutical testing laboratory. We provide identity, purity, and potency analyses necessary to characterize microbiome products and we have a proven track record on a variety of Microbiome programs including Spore Fraction and Defined Drug Product manufacturing processes. Boston Analytical employs LabWare Inc.’s™ LIMS and ELN software to help ensure on-time and accurate results.
Clinical Microbiomics | MS Omics | CosmosID
Exhibition Partner
We offer end-to-end solutions for microbiome science from discovery through clinical validation. Untangle the complexity of the microbiome with CLIA-certified & ICH-GCP compliant NGS and metabolomics services and bioinformatics solutions. Results can be accessed via the CosmosID-HUB, a user-friendly and interactive software for microbiome analysis, or through customized reporting. Unravel complexities of microbial communities and decode genetic and metabolic fingerprints with advanced bioinformatic pipelines that enable clonal-level resolution, engraftment persistence analysis correlated to clinical outcomes and in silico screens that de-risk strain selection and reduce development time. Our expertise in integrative systems biology and immunology will provide the support you need to understand the microbiome in health and disease.
SGS Quay Pharmaceuticals
Exhibition Partner
SGS Quay Pharmaceuticals is experienced in providing a comprehensive out-sourcing service for formulation and analytical development with subsequent clinical trials manufacturing for pharmaceutical and biotechnology companies worldwide.
By far, our most important asset is an exceptional depth of knowledge and experience that enables us to design novel and effective drug delivery systems built on a fundamental scientific and technical understanding of our clients’ requirements.